IL-33/ST2 signaling contributes to radicular pain by modulating MAPK and NF-κB activation and inflammatory mediator expression in the spinal cord in rat models of noncompressive lumber disk herniation

J Neuroinflammation. 2018 Jan 12;15(1):12. doi: 10.1186/s12974-017-1021-4.

Abstract

Background: Immune and inflammatory responses occurring in the spinal cord play a pivotal role in the progression of radicular pain caused by intervertebral disk herniation. Interleukin-33 (IL-33) orchestrates inflammatory responses in a wide range of inflammatory and autoimmune disorders of the nervous system. Thus, the purpose of this study is to investigate the expression of IL-33 and its receptor ST2 in the dorsal spinal cord and to elucidate whether the inhibition of spinal IL-33 expression significantly attenuates pain-related behaviors in rat models of noncompressive lumbar disc herniation.

Methods: Lentiviral vectors encoding short hairpin RNAs that target IL-33 (LV-shIL-33) were constructed for gene silencing. Rat models of noncompressive lumber disk herniation were established, and the spines of rats were injected with LV-shIL-33 (5 or 10 μl) on the first day after the operation. Mechanical thresholds were evaluated during an observation period of 21 days. Moreover, the expression levels of spinal tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and cyclooxygenase 2 (COX-2) and the activation of the mitogen-activated protein kinases (MAPK) and nuclear factor-κB (NF-κB) pathways were evaluated to gain insight into the mechanisms related to the contribution of IL-33/ST2 signaling to radicular pain.

Results: The application of nucleus pulposus (NP) to the dorsal root ganglion (DRG) induced an increase in IL-33 and ST2 expression in the spinal cord, mainly in the dorsal horn neurons, astrocytes, and oligodendrocytes. Spinally delivered LV-shIL-33 knocked down the expression of IL-33 and markedly attenuated mechanical allodynia. In addition, spinal administration of LV-shIL-33 reduced the overexpression of spinal IL-1β, TNF-α, and COX-2 and attenuated the activation of C-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and NF-κB/p65 but not p38.

Conclusions: This study indicates that spinal IL-33/ST2 signaling plays an important role in the development and progression of radicular pain in rat models of noncompressive lumber disk herniation. Thus, the inhibition of spinal IL-33 expression may provide a potential treatment to manage radicular pain caused by intervertebral disk herniation.

Keywords: IL-33/ST2 signaling; Inflammatory mediator; Lumber disk herniation; MAPK; NF-κB; Radicular pain.

MeSH terms

  • Animals
  • Cells, Cultured
  • Disease Models, Animal
  • Inflammation Mediators / metabolism*
  • Interleukin-33 / antagonists & inhibitors
  • Interleukin-33 / biosynthesis*
  • Interleukin-33 / genetics
  • Intervertebral Disc Displacement / metabolism*
  • Intervertebral Disc Displacement / pathology
  • Lentivirus / genetics
  • Lumbar Vertebrae / injuries
  • Lumbar Vertebrae / metabolism
  • Lumbar Vertebrae / pathology
  • MAP Kinase Signaling System / physiology
  • Male
  • NF-kappa B / biosynthesis
  • NF-kappa B / genetics
  • Pain / metabolism
  • Pain / pathology
  • RNA, Small Interfering / administration & dosage
  • RNA, Small Interfering / genetics
  • Radiculopathy / metabolism*
  • Radiculopathy / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Interleukin-1 / biosynthesis*
  • Spinal Cord / metabolism*
  • Spinal Cord / pathology

Substances

  • Il33 protein, rat
  • Inflammation Mediators
  • Interleukin-33
  • NF-kappa B
  • RNA, Small Interfering
  • Receptors, Interleukin-1
  • ST2 protein, rat